← Leaderboards
Elena Losina
Boston University Medical Campus
$29,697,495
Attributed
$31,034,459
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,034,459 · 16
By mechanism
R01$18,896,186 · 5
P30$3,020,649 · 3
T32$2,673,929 · 1
P60$2,673,244 · 2
K24$1,736,033 · 1
K25$696,512 · 1
Top collaborators
- Jeffrey Neil Katz10 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Jared W. Magnani$9,122,964
- Sarah Hall Gordon$1,315,054
- Kevin Griffith$40,457
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationPersonsProgramsDesignCostCost EffectivenessMusculoskeletalEnsureBaseMethodologyMultidisciplinaryQuality Of LifePhysical ActivityPainClinical ResearchReportingBehavioralOperative Surgical ProceduresKnee OsteoarthritisDegenerative PolyarthritisObesityCost EffectiveGrantDisability
Grant awards (74)
HIV and musculoskeletal frailty: implications for care, policy and research$1,727,982
R01 · FY2025 · NR · contact PI
Optimizing the value of pain management in knee OA patients with comorbidities$732,876
R01 · FY2025 · AR · contact PI
Knee Arthroplasty Activity Trial (KArAT)$659,899
R01 · FY2025 · AR · contact PI
Methodologic Core$278,640
P30 · FY2025 · AR · contact PI
HIV and musculoskeletal frailty: implications for care, policy and research$869,878
R01 · FY2024 · NR · contact PI
Optimizing the value of pain management in knee OA patients with comorbidities$790,316
R01 · FY2024 · AR · contact PI
Knee Arthroplasty Activity Trial (KArAT)$717,317
R01 · FY2024 · AR · contact PI
Methodologic Core$324,432
P30 · FY2024 · AR · contact PI
HIV and musculoskeletal frailty: implications for care, policy and research$859,206
R01 · FY2023 · NR · contact PI
Knee Arthroplasty Activity Trial (KArAT)$747,091
R01 · FY2023 · AR · contact PI
Methodologic Core$327,566
P30 · FY2023 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program (COMET)$303,804
T32 · FY2023 · AR
HIV and musculoskeletal frailty: implications for care, policy and research$901,598
R01 · FY2022 · NR · contact PI
Knee Arthroplasty Activity Trial (KArAT)$811,152
R01 · FY2022 · AR · contact PI
Optimizing the value of pain management in knee OA patients with comorbidities$717,213
R01 · FY2022 · AR · contact PI
Methodologic Core$328,952
P30 · FY2022 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program (COMET)$293,328
T32 · FY2022 · AR
Optimizing the value of pain management in knee OA patients with comorbidities$707,306
R01 · FY2021 · AR · contact PI
Methodology core$364,236
P30 · FY2021 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program (COMET)$24,617
T32 · FY2021 · AR
Optimizing the value of pain management in knee OA patients with comorbidities$729,260
R01 · FY2020 · AR · contact PI
Knee Arthroplasty AcTivity (KArAT) Trial$463,259
U56 · FY2020 · AR · contact PI
Methodology core$365,057
P30 · FY2020 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program (COMET)$304,002
T32 · FY2020 · AR
Optimizing the value of pain management in knee OA patients with comorbidities$709,733
R01 · FY2019 · AR · contact PI
Methodology core$354,807
P30 · FY2019 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program (COMET)$323,506
T32 · FY2019 · AR
Patient Oriented Research and Mentoring Program in Orthopedics$183,168
K24 · FY2019 · AR · contact PI
Optimizing the value of pain management in knee OA patients with comorbidities$749,066
R01 · FY2018 · AR · contact PI
Methodology core$345,068
P30 · FY2018 · AR · contact PI
Patient Oriented Research and Mentoring Program in Orthopedics$184,248
K24 · FY2018 · AR · contact PI
Clinical impact and cost-effectiveness of pain management in knee OA$642,016
R01 · FY2017 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program$361,679
T32 · FY2017 · AR
Methodology core$331,891
P30 · FY2017 · AR · contact PI
Studying Physical Activity Rewards and Telephonic Active Coaching$222,572
U34 · FY2017 · AR · contact PI
Patient Oriented Research and Mentoring Program in Orthopedics$183,168
K24 · FY2017 · AR · contact PI
Clinical impact and cost-effectiveness of pain management in knee OA$660,121
R01 · FY2016 · AR · contact PI
Methodology Core$355,197
P60 · FY2016 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program$338,188
T32 · FY2016 · AR
Studying Physical Activity Rewards and Telephonic Active Coaching$241,947
U34 · FY2016 · AR · contact PI
Patient Oriented Research and Mentoring Program in Orthopedics$184,248
K24 · FY2016 · AR · contact PI
Clinical impact and cost-effectiveness of pain management in knee OA$650,717
R01 · FY2015 · AR · contact PI
Methodology Core$355,195
P60 · FY2015 · AR · contact PI
Patient Oriented Research and Mentoring Program in Orthopedics$184,815
K24 · FY2015 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program$184,256
T32 · FY2015 · AR
Clinical impact and cost-effectiveness of pain management in knee OA$657,711
R01 · FY2014 · AR · contact PI
Methodology Core$348,920
P60 · FY2014 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program$245,172
T32 · FY2014 · AR
Study of Physical Activity Rewards after Knee Surgery (SPARKS)$190,498
R21 · FY2014 · AR · contact PI
Patient Oriented Research and Mentoring Program in Orthopedics$164,035
K24 · FY2014 · AR · contact PI
Clinical impact and cost-effectiveness of pain management in knee OA$686,037
R01 · FY2013 · AR · contact PI
Methodology Core$327,589
P60 · FY2013 · AR · contact PI
Clinical Orthopaedic and Musculoskeletal Education and Training Program$295,377
T32 · FY2013 · AR
Study of Physical Activity Rewards after Knee Surgery (SPARKS)$219,630
R21 · FY2013 · AR · contact PI
Patient Oriented Research and Mentoring Program in Orthopedics$164,195
K24 · FY2013 · AR · contact PI
Methodology Core$347,042
P60 · FY2012 · AR · contact PI
Patient Oriented Research and Mentoring Program in Orthopedics$164,380
K24 · FY2012 · AR · contact PI
Methodology Core/Biometry Core$205,207
P60 · FY2011 · AR · contact PI
Patient Oriented Research and Mentoring Program in Orthopedics$164,053
K24 · FY2011 · AR · contact PI
Knee OA: Setting Priorities for Care, Policy, Research$632,252
R01 · FY2010 · AR · contact PI
Methodology Core/Biometry Core$195,815
P60 · FY2010 · AR · contact PI
Patient Oriented Research and Mentoring Program in Orthopedics$159,723
K24 · FY2010 · AR · contact PI
Knee OA: Setting Priorities for Care, Policy, Research$641,055
R01 · FY2009 · AR · contact PI
Methodology Core/Biometry Core$195,841
P60 · FY2009 · AR · contact PI
Knee OA: Setting Priorities for Care, Policy, Research$628,748
R01 · FY2008 · AR · contact PI
Methodology Core/Biometry Core$189,810
P60 · FY2008 · AR · contact PI
Knee OA: Setting Priorities for Care, Policy, Research$632,092
R01 · FY2007 · AR · contact PI
Methodology Core/Biometry Core$152,628
P60 · FY2007 · AR · contact PI
Knee OA: Setting Priorities for Care, Policy, Research$635,544
R01 · FY2006 · AR · contact PI
Modeling Sequential Antiretroviral Therapy in HIV$140,967
K25 · FY2005 · AI
Modeling Sequential Antiretroviral Therapy in HIV$140,967
K25 · FY2004 · AI
Modeling Sequential Antiretroviral Therapy in HIV$140,967
K25 · FY2003 · AI
Modeling Sequential Antiretroviral Therapy in HIV$140,967
K25 · FY2002 · AI
Modeling Sequential Antiretroviral Therapy in HIV$132,644
K25 · FY2001 · AI